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cyte mitochondria as well as the effect on signalling pathways leading to
altered collagenase expression.
Methods: RNA intereference was used to characterise whether the reduc-
tion of SOD2 levels affects matrix metalloproteinase (MMP)-1 and MMP-13
gene expression along with superoxide levels produced by the mitochon-
dria in human articular chondrocytes (HAC). For the MMP-1 and MMP-13
expression, cells were then serum starved for 24 hours and stimulated
with IL-1. MMP-1 and MMP-13 mRNA levels were determined by real-time
RT-PCR. To assess the levels of superoxide and SOD2 protein, HAC were
stained with MitoSOX™ -Red, a speciﬁc indicator for superoxide in the
mitochondria, or an anti-SOD2 antibody. To compare the mitochondrial
respiratory activity between HAC from healthy patients (neck of femur
fractures, NOF) and from osteoarthritic patients (OA), cells were cultured
for 3 days after extraction from the cartilage and analysed for respiratory
activity using the Oroboros Oxygraph-2k respirometry system.
Results: SOD2 depletion by RNA interference led to a signiﬁcant decrease
in basal MMP-1 mRNA expression and a signiﬁcant reduction in the level
of MMP-1 and MMP-induction following IL-1 stimulation. SOD2 depletion
by RNA interference also led to a signiﬁcant increase in mitochondrial
superoxide levels.
In terms of respiratory capacity, OA chondrocytes have on average 65%
higher respiratory chain capacity than NOF chondrocytes. However, al-
though OA chondrocytes have a more active respiratory chain, it appears
less eﬃcient (25%) to that of HAC from NOF patients.
Conclusions: Depletion of SOD2 in OA chondrocytes leads to a signiﬁcant
decrease in the expression levels of the collagenases MMP-1 and MMP13,
indicating that the decrease of SOD2 expression in OA cartilage may rep-
resent a chondroprotective mechanism. However, this depletion leads to a
signiﬁcant increase of mitochondrial superoxide levels. Combined with the
increased levels of unutilised protons and electrons in the respiratory chain,
these effects can potentially alter the mitochondrial membrane potential of
the cells causing cellular dysfunction.
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GLATIRAMER ACETATE (GA), A PEPTIDE IMMUNOMODULATORY DRUG,
INHIBITS INFLAMMATORYMEDIATORS, MMP-13 ACTIVITY AND
COLLAGEN DEGRADATION IN OA CARTILAGE
M. Attur, J. Millman, M. Dave, H. Al-Mussawir, J. Patel, G. Palmer,
S.B. Abramson
NYUHosp. for Joint Diseases, New York, NY
Purpose: Glatiramer acetate (GA), the generic name for Copaxone, is an
immunomodulatory agent used in the treatment of multiple sclerosis,
which has been to shown to induce interleukin-1 receptor antagonist (IL-
1Ra) production in macrophages and microglial cells. In osteoarthritis, the
production of inﬂammatory mediators, particularly IL-1 by chondrocytes,
may be important in the pathogenesis and progression of OA. We therefore
tested the effects of GA on the catabolic activities of chondrocytes in OA
cartilage explants cultures.
Methods: Cartilage slices were obtained from the knees of patients with
advanced OA and undergoing knee replacement surgery. Non-arthritic
knee cartilages were obtained from autopsy patients within 24h (NDRI,
Philadelphia). Matrix metalloproteinases proMMP-13 ELISA kits were from
R&D Systems, (Minneapolis, MN). Predesigned TaqMan PCR primers were
purchased from Applied Biosystems (CA).
Results: We have previously shown that OA cartilage explant cultures
spontaneously release inﬂammatory mediators such as nitric oxide,
Prostaglandin E2 (PGE2), interleukins including IL-1betaand matrix metal-
loproteinases (MMPs). In this study we evaluated the chondroprotective
property of GA in monolayer cultures of primary OA chondrocytes and
cartilage explant cultures. GA (5-100ug/ml) treatment dose dependently
increased transcription (QPCR) and production (ELISA) of sIL-1Ra (p>0.001)
in normal and OA Chondrocytes. GA also intrinsically increased (p<0.001)
sIL-1Ra production by OA cartilage explant cultures. Furthermore, addition
of GA: 1) inhibited both spontaneous and IL-1 induced inﬂammatory
mediators such as nitric oxide (NO) (9.0+1.5 to 1.5+0.5 uM; p<0.01)
and PGE2 (100.6+18.5 to 15.1+6.1 ng/ml; p<0.01) production; 2) inhib-
ited spontaneous and IL-1 induced proMMP-13 secretion (200.6+90.5 to
78.5+15.1ng/ml; p<0.001); 3) inhibited APMA activated total MMP-13
activity by more than 30-50% (p<0.01); 4) inhibited collagen degradation
as assayed by CTXII ELISA (17.4+1.7 to 4.5+1.9 ng/ml; p<0.01). All these
chondroprotective effects of GA were dose dependent and signiﬁcance was
reached between 10-100 ug/ml.
Conclusion: Glatiramer acetate is a complex heterogeneous mixture of
polypeptides that exhibits “chondroprotective” properties in OA cartilage,
inhibiting the production of inﬂammatory mediators as well as MMP-13
expression/activation. The data suggest that these effects may be due
to upregulation of IL-1Ra. Based on these studies, we propose that GA
may have potential for disease modifying properties in OA and should be
evaluated in vivo animal studies.
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ADIPONECTIN AND LEPTIN EXHIBIT DIFFERENT PATTERN OF
PRODUCTION IN CARTILAGE FROM PATIENTS WITH OSTEOARTHRITIS
P.-J. Francin, C. Guillaume, P. Gegout-Pottie, P. Netter, D. Mainard, N. Presle
UMR 7561 CNRS-Nancy Univ., Vandoeuvre les Nancy, France
Purpose. Based on the association between obesity and osteoarthritis (OA),
increasing studies aimed to determine the contribution of adipokines in
OA. As adiponectin and leptin may exhibit opposite inﬂammatory effects
and display different patterns of distribution between the joint and the
circulating compartment, we compared the production of both adipokines
in cartilage from human OA-affected joints in relation with the grade of
cartilage destruction and with the Body Mass Index (BMI) of the patients.
Methods. The production of leptin and adiponectin was determined by
ELISA in conditioned media from cultured full-depth cartilage biopsies
obtained from patients with OA. The severity of OA cartilage lesion was
then evaluated after histological analysis of each specimen and was graded
using the Mankin score.
Results. The results indicated that the production of adiponectin in OA
cartilage are quite different from that of leptin. A positive association has
been found between the BMI of the patients and the production level of
leptin while the synthesis of adiponectin did not change with the BMI.
In addition, a grade-dependent increase in the production level of leptin
was shown for non obese patients (BMI<30kg/m2). The synthesis of leptin
strongly increased in obese patients (BMI>30kg/m2) between the low and
the moderate OA grades, but did not change anymore for the most severe
OA grade. The adiponectin production was slightly elevated in cartilage
samples with moderate or advanced OA compared to specimens with low
histological OA score, but the difference did reach statistical signiﬁcance.
Conclusion. These ﬁndings indicated that leptin and adiponectin exhibit
different pattern of production in OA cartilage. The leptin level is strongly
associated with both the grade of cartilage destruction and the BMI of the
patients. Conversely, the production of adiponectin is slightly up-regulated
in damaged cartilage independently of the OA score and the BMI of the
patients.
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WNT3A MODULATES CHONDROCYTE PHENOTYPE THROUGH ACTIVATION
OF BOTH CANONICAL AND NON-CANONICAL PATHWAYS
G. Nalesso1 , P. Achan2, C. Pitzalis1, F. Dell’Accio1
1Ctr. for Experimental Med. and Rheumatology, William Harvey Res. Inst.,
Barts and the London Sch. of Med. and Dentistry, London, United Kingdom;
2Dept. of Orthopaedics, Barts and the Royal London Hosp., London, United
Kingdom
Purpose: Injury to the articular cartilage results in the activation of Wnt sig-
nalling which may represent a homeostatic mechanism. Indeed disruption
of Wnt signalling results in osteoarthritis both in humans and experimental
models. Wnt ligands are traditionally categorized based on their capacity
to activate either the β-catenin-dependent canonical pathway or any of the
non canonical pathways including the Ca2+/Calmodulin-dependent kinase II
(CaMKII)-dependent or the PKA-dependent pathways, the planar cell polar-
ity pathway and the Wnt/ROR-mediated pathway. The clear-cut separation
between canonical and non-canonical Wnts has been recently challenged
and therefore the purpose of the study was to investigate through which
pathway Wnt3a modulates the cartilage phenotype and regulates cartilage
homeostasis in human articular chondrocytes.
Methods: Primary adult human articular chondrocytes were isolated from
preserved areas of the cartilage of patients undergoing knee arthroplasty
for osteoarthritis. Detection of protein and protein phosphorylation upon
Wnt3a stimulation was evaluated by western blotting. Intracellular calcium
mobilization was detected by cellular accumulation of FURA-4 dye. The
activation of the canonical pathway upon Wnt3a stimulation was evaluated
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by reporter assay, nuclear accumulation of β-catenin (Western blotting), or
expression of Axin-2 mRNA. Gene expression analysis of chondrocyte mark-
ers including Col2A1, Col1A1, Col10A1, Aggrecan, Sox9, MMP3, MMP13,
ADAMTS5 was performed by quantitative real time PCR.
Results: Wnt3a induced the activation of both the canonical and the
CaMKII-dependent pathways. More importantly, using a systematic strat-
egy of blockade of the different pathways, we have separated the effects
that are directly dependent on the activation of the canonical pathway,
including proliferation, from those that are non-canonical such as disrup-
tion of the chondrocyte phenotype, as evaluated by downregulation of
differentiation markers, and cell survival. Most importantly we have built
up a model in which, through reciprocal inhibition of these two pathways,
either excessive Wnt3a stimulation or blockade equally leads to cartilage
breakdown.
Conclusions: – Wnt3a can activate either the canonical or the CaMKII-
dependent Wnt signaling pathway in adult human articular chondrocytes
– The β-catenin and the CaMKII-dependent Wnt pathways are reciprocally
inhibitory
– The Wnt3a-dependent canonical and non canonical pathway activation
has distinct outcomes
226
ALARMINS S100A8 AND S100A9 SKEW CHONDROCYTES TOWARDS A
CARTILAGE BREAKDOWN PHENOTYPE IN HUMAN OSTEOARTHRITIS
R.F. Schelbergen1, P.L. van Lent1, A.B. Blom1, A. Sloetjes1, T. Vogl2,
J. Roth2, W.B. van den Berg1
1Dept. of Rheumatology, Radboud Univ. Med. Ctr., Nijmegen, Netherlands;
2Inst. of Immunology, Univ. of Muenster, Muenster, Germany
Purpose: Alarmins S100A8 and S100A9 are members of the S100 fam-
ily of Ca2+-binding proteins that are associated with inﬂammation and
bone erosion during human rheumatoid arthritis (RA). Recently, we found
that S100A8 and S100A9 are also associated with cartilage degradation
in murine collagenase-induced osteoarthritis (OA). We also showed that
S100A8 and S100A9 stimulate expression and activity of matrix metallopro-
teinases (MMPs) and pro-inﬂammatory cytokines in murine chondrocytes.
We now investigated whether S100A8, S100A9 and/or S100A8/S100A9
complex could also activate human chondrocytes from OA patients and
skew them towards a cartilage breakdown phenotype.
Methods: Cartilage was collected from human OA patients undergoing joint
replacement. Immunostaining was performed on paraﬃn sections of OA
cartilage using antibodies against S100A8 and S100A9 and against VDIPEN
and NITEGE, which are MMP- and A disintegrin and metalloproteinase with
thrombospondin motifs (ADAMTS)-induced cartilage breakdown neoepi-
topes. Chondrocytes were isolated from OA cartilage and stimulated with
recombinant S100A8, S100A9, S100A8/A9 heterodimer and/or interleukin
1 beta (IL-1beta). mRNA levels of MMPs, cytokines and cartilage matrix
molecules were determined with RT-qPCR and protein levels of MMP and
cytokine using Luminex.
Results: Immunostaining on OA cartilage showed that both S100A8 and
S100A9 protein were expressed in and around chondrocytes. Furthermore,
immunostaining of breakdown neoepitopes VDIPEN and NITEGE was found
in the same areas as the S100 proteins.
Stimulation of OA chondrocytes with the monomers S100A8 and S100A9
for 24 hours strongly stimulated cartilage degrading molecules like MMPs
and cytokines. mRNA expression of MMP1, -3, -9 and -13 was upregulated
4-, 4-, 3- and 3-fold respectively. Protein levels of MMP1, -3 and -13
were upregulated 234, 27 and 136% respectively. Moreover, particularly
interleukin 6 (IL-6) levels were strongly upregulated on mRNA level (11-
fold) and protein levels reached 5 ng/ml. The catabolic effect of S100A8
and S100A9 was almost comparable to IL-1beta effects, but there was no
additive effect of S100 with IL-1beta, suggesting independent mechanisms.
Apart from stimulating cartilage degradation, S100A8 and S100A9
monomers also inhibited new formation of cartilage matrix molecules.
mRNA levels of aggrecan and collagen type II were signiﬁcantly decreased
2- to 3-fold, suggesting that these proteins inhibit repair.
In contrast to the monomers, the heterodimer S100A8/A9 neither had effect
on cartilage degradation nor on cartilage matrix production.
Conclusions: S100A8 and S100A9 expression is found in areas with car-
tilage breakdown in OA cartilage. Moreover these proteins inhibit new
formation of matrix molecules and stimulate production of cartilage
degrading molecules thereby skewing chondrocytes towards a cartilage
breakdown phenotype.
S100A8 and/or S100A9 may serve as therapeutic targets for the treatment
of cartilage damage during OA.
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EFFECTS OF TGF-BETA ON OA CHONDROCYTE MITOCHONDRIA
A. Mates, A. Pearsall IV, V. Grishko
Univ. of South Alabama, Mobile, AL
Purpose: TGF- beta is a powerful anabolic factor for chondrocytes and plays
an important role by enhancing cartilage repair. Oxidative stress and mito-
chondrial damage have been found to promote cell death, functional failure
and degeneration. There is a growing body of evidence that mitochondrial
dysfunction is present during the progression of osteoarthritis. The purpose
of the present study was to evaluate whether TGF-beta enhances cartilage
repair through the prevention of mitochondrial DNA damage and dys-
function in human OA chondrocytes subjected to experimentally-induced
oxidative stress.
Methods: Primary OA chondrocytes cultures, generated from cartilage from
patients undergoing total knee replacement, were exposed for 30 min to
reactive oxygen species (ROS) generators xanthine oxidase/hypoxanthine
or peroxynitrite. Some cells were pre-incubated with 5 ng/ml of TGF-beta
for 24 h prior to treatment. In some experiments cells were incubated
for 48 h with IL-1 beta or TNF-alpha alone or in combination with TGF-
beta. Following exposure, cells were immediately lysed for DNA isolation,
protein isolation, ATP analysis, or replenished with normal growth media
and left for recovery and then analyzed. Mitochondrial dysfunction was
assessed in terms of mitochondrial DNA damage (Quantitative Southern
blot analysis), ATP content (Bioluminescence kit), mitochondrial proteins
levels (Western blot). Cell viability and apoptosis were evaluated by ﬂow
cytometry. Additionally, Western blot was applied to perform caspase 9
cleavage assay.
Results: When OA chondrocytes were exposed to ROS generators, mito-
chondrial dysfunction and apoptosis were accumulated as a consequence.
Pretreatment with TGF- beta preserved mitochondrial DNA integrity, ATP
levels, and restored drop in mitochondrial protein levels. Moreover, TGF-
beta enhanced chondrocytes viability and diminished the appearance of
apoptosis. The similar results were obtained for IL-1 beta and TNF-alpha.
Interestingly, TGF-beta did not have effect on nitric oxide levels enhanced
following pro-inﬂammatory cytokine exposure of chondrocytes.
Conclusions: The present results demonstrate for the ﬁrst time the mi-
toprotective properties of TGF-beta and offer additional explanation of
the mechanisms through which TGF-beta enhances cartilage repair. More
studies required evaluating more precisely the observed TGF- beta effects.
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P38 AND MEK/ERK MAP KINASES REGULATE COMMON AND UNIQUE
GENE SETS IN CHONDROCYTES
V. Ulici, L.-A. Stanton, C.G. James, F. Beier
Univ. Of Western Ontario, London, ON, Canada
Purpose: The cartilage growth plate regulates growth of endochondral
bones, and ectopic initiation of growth plate events (e.g. chondrocyte
hypertrophy) in articular chondrocytes contributes to the development of
osteoarthritis. MAPK signaling pathways have been implicated in different
aspects of growth plate development. In this study we focus on two
MAPK pathways: p38 and MEK/ERK. We analyzed the effects of these two
pathways on mouse growth plate chondrocyte gene expression and bone
growth in culture. Some of the speciﬁc roles of the p38 and MEK/ERK
pathways have been already investigated, but no study so far reported on
the effects of their simultaneous inhibition. We hypothesized that these
two signaling pathways have antagonizing roles in different aspects of the
growth plate development and the simultaneous inhibition will result in a
reduction of their speciﬁc effects.
Methods: RNA was isolated from mouse growth plate chondrocytes af-
ter 24 hours of culture in the presence of UO126 (MEK/ERK inhibitor),
SB202190 (p38 inhibitor) or DMSO (control) and hybridized to Affymetrix
MOE 430 2.0 gene chips (n = 3). The data were normalized and analyzed
using GeneSpring GX 7.3.1 and Ingenuity Pathway Analysis (IPA). The
expression of selected genes was conﬁrmed by real-time PCR. In addition,
mouse embryonic tibiae were cultured for 6 days in the presence of DMSO,
SB202190 (SB), UO126 (U) or SB202190+ UO126 (SU). Bone growth was
